Biosyent Inc (RX.V)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of CA$10,000 in Biosyent Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Biosyent Inc (RX.V) has returned 13.69% so far this year and 31.43% over the past 12 months. Over the last ten years, RX.V has returned 8.04% per year, falling short of the S&P 500 Index benchmark, which averaged 12.91% annually.

Based on dividend-adjusted daily data since May 8, 1996, RX.V's average daily return is +0.58%, while the average monthly return is +4.12%. At this rate, your investment would double in approximately 1.4 years.

Historically, 48% of months were positive and 52% were negative. The best month was Nov 2002 with a return of +200.0%, while the worst month was Sep 2002 at -75.0%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.

On a daily basis, RX.V closed higher 29% of trading days. The best single day was Dec 14, 2001 with a return of +400.0%, while the worst single day was Sep 30, 2002 at -75.0%.

Biosyent Inc has an annualized alpha of 92.24%, beta of 0.37, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since May 09, 1996.

• This stock captured 181.84% of S&P 500 Index gains but only 24.69% of its losses — a favorable profile for investors.
• Beta of 0.37 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

RX.V ranks 76 for risk / return — better than 76% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Biosyent Inc (RX.V) and compare them to a chosen benchmark (S&P 500 Index).

Biosyent Inc provided a 1.42% dividend yield over the last twelve months, with an annual payout of CA$0.21 per share. The company has been increasing its dividends for 3 consecutive years.

The table displays the monthly dividend distributions for Biosyent Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Biosyent Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biosyent Inc was 99.69%, occurring on Dec 13, 2001. Recovery took 3075 trading sessions.

The current Biosyent Inc drawdown is 8.68%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Biosyent Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Biosyent Inc is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.